Research
Mixed
Combination therapies (polytherapies) targeting multiple biological mechanisms simultaneously are more likely to produce sustained weight loss and reduce side effects compared to monotherapies.
Combining different weight-loss medications that target different pathways (polytherapy) may be more effective and have fewer side effects than using a single drug. This approach aims to overcome the body's natural counter-regulation to weight loss. Discuss with your doctor if a combination therapy is suitable for you.
ModerateSupportsMEDIUM confidence
Advantages of polytherapy, which actually began some 20 years ago with the phentermine and fenfluramine combination, include the use of lower drug doses, possible synergistic but at least additive weight loss, less serious side effects and reduced potential for counter-regulation
Why this rating
Based on theoretical advantages and some clinical trials, but regulatory hurdles remain.
Source
Anti-obesity drugs: past, present and future
R.J. Rodgers et al. · Disease Models & Mechanisms · 2012
DOI 10.1242/dmm.009621
narrative_reviewCited 434×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →